| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |